General Information of the Compound
Compound ID
CP0533346
Compound Name
3-[(3-methylphenyl)methyl]-2-pentan-3-yl-7-piperazin-1-ylimidazo[4,5-b]pyridine
    Show/Hide
Structure
Formula
C23H31N5
Molecular Weight
377.536
Canonical SMILES
CCC(CC)c1nc2c(ccnc2n1Cc1cccc(C)c1)N1CCNCC1
    Show/Hide
InChI
InChI=1S/C23H31N5/c1-4-19(5-2)22-26-21-20(27-13-11-24-12-14-27)9-10-25-23(21)28(22)16-18-8-6-7-17(3)15-18/h6-10,15,19,24H,4-5,11-14,16H2,1-3H3
    Show/Hide
InChIKey
AMEIVCNGERIVGC-UHFFFAOYSA-N
Physicochemical Property
logP
4.10122
Rotatable Bonds
6
Heavy Atom Count
28
Polar Areas
45.98
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 126720444
ChEMBL ID
CHEMBL4171504
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 42 nM
   TI
   LI
   LO
   TS